2,4-diamino-6-[[(1S)-1-[3-(3-aminopropyl)-5-chloro-4-oxoquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile
C19H22ClN9O — CID 118573718
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,4-diamino-6-[[(1S)-1-[3-(3-aminopropyl)-5-chloro-4-oxoquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile
2,4-diamino-6-[[(1S)-1-[3-(3-aminopropyl)-5-chloro-4-oxoquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile (PubChem CID 118573718) has the molecular formula C19H22ClN9O and a molecular weight of 427.90 g/mol. Its IUPAC name is 2,4-diamino-6-[[(1S)-1-[3-(3-aminopropyl)-5-chloro-4-oxoquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile.
Molecular Properties
| Compound Name | 2,4-diamino-6-[[(1S)-1-[3-(3-aminopropyl)-5-chloro-4-oxoquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile |
|---|---|
| PubChem CID | 118573718 |
| Molecular Formula | C19H22ClN9O |
| Molecular Weight | 427.90 g/mol |
| Exact Mass | 427.16 |
| IUPAC Name | 2,4-diamino-6-[[(1S)-1-[3-(3-aminopropyl)-5-chloro-4-oxoquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile |
| SMILES | CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1CCCN |
| InChI | InChI=1S/C19H22ClN9O/c1-2-12(25-16-10(9-22)15(23)27-19(24)28-16)17-26-13-6-3-5-11(20)14(13)18(30)29(17)8-4-7-21/h3,5-6,12H,2,4,7-8,21H2,1H3,(H5,23,24,25,27,28)/t12-/m0/s1 |
| InChIKey | NFUUFQCPVNUJBV-LBPRGKRZSA-N |
| XLogP | 1.79 |
| TPSA | 174.55 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.90 |
| LogP ≤ 5 | 1.79 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118573718 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.